Pfizer wins the final nullification trial on the use patent of Lyrica
Pfizer has won the final nullification trial filed by generic companies on the use patent of ‘Lyrica(generic name: pregabalin).’ The Supreme Court made a final ruling the use patent of Lyrica was valid on the 14th.
Under the final ruling of the Supreme Court, the Lyrica’s treatment of pains, suc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
